All posts related to "Alerts"

Health Canada warning about Benlysta (belimumab) for systemic lupus erythematosus

Serious adverse events of depression, suicidal ideation or behaviour, or self-injury were reported more frequently in patients with systemic lupus erythematosus receiving Benlysta than in patients receiving placebo during a post-marketing study 

Below is an excerpt from the safety alert published by Health Canada

Information for consumers

Benlysta is used in combination with other medicines to treat adults with lupus (systemic lupus erythematosus).

Continue reading